TG Therapeutics Inc (TGTX)

Debt-to-equity ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Long-term debt	US$ in thousands	244,429	244,158	102,537	101,326	100,118	98,908	97,700	96,503	71,135	71,135	68,947	67,249	66,788	—	—	—	7,716	15,074	22,233	29,201
Total stockholders’ equity	US$ in thousands	222,364	192,157	177,568	160,109	160,502	164,769	40,453	27,433	58,587	100,481	129,035	170,386	237,153	311,517	383,130	445,285	519,350	170,658	194,227	-1,353
Debt-to-equity ratio		1.10	1.27	0.58	0.63	0.62	0.60	2.42	3.52	1.21	0.71	0.53	0.39	0.28	0.00	0.00	0.00	0.01	0.09	0.11	—

December 31, 2024 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $244,429K ÷ $222,364K
= 1.10

TG Therapeutics Inc's debt-to-equity ratio has shown significant fluctuations over the past few years. The ratio was not available for March 31, 2020, but it started at 0.11 on June 30, 2020, indicating a moderate level of debt relative to equity.

From December 2020 to March 2021, the ratio steadily decreased to 0.00, suggesting a minimal debt position compared to equity. This trend continued until September 2021. However, from December 2021 to June 2022, the ratio increased substantially to 1.21, indicating a significant rise in indebtedness relative to equity.

The debt-to-equity ratio further escalated to 3.52 by March 31, 2023, reflecting a substantial increase in debt compared to equity. This high ratio may raise concerns about the company's financial leverage and ability to meet its debt obligations.

By June 30, 2024, the ratio had decreased to 0.58, suggesting a more balanced capital structure. However, it increased again to 1.10 by December 31, 2024, indicating a significant level of debt relative to equity, albeit lower than the peak in March 2023.

Overall, the fluctuations in TG Therapeutics Inc's debt-to-equity ratio highlight varying levels of financial leverage and the need for careful monitoring of the company's debt management and capital structure going forward.